# Cotrifazid Safety and Efficacy Against Malaria

> **NCT00322907** · PHASE2 · TERMINATED · sponsor: **Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland** · enrollment: 330 (—)

## Conditions studied

- Clinical Malaria

## Interventions

- **DRUG:** Cotrifazid vs mefloquine or quinine+SP

## Key facts

- **NCT ID:** NCT00322907
- **Lead sponsor:** Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-04
- **Primary completion:** —
- **Final completion:** 2003-01
- **Target enrollment:** 330 (—)
- **Last updated:** 2006-05-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00322907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00322907, "Cotrifazid Safety and Efficacy Against Malaria". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00322907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*